Search
Now showing items 1-1 of 1
Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection
(2007)
Background: Although the role of immunoglobulin E (IgE) in immunity against helminth parasites is unclear, there is concern that therapeutic antibodies that neutralize IgE (anti-IgE) may be unsafe in subjects at risk of ...